HK94694A - Polycyclic quinoline, naphtyridine and pyrazinopyridine derivatives - Google Patents

Polycyclic quinoline, naphtyridine and pyrazinopyridine derivatives

Info

Publication number
HK94694A
HK94694A HK94694A HK94694A HK94694A HK 94694 A HK94694 A HK 94694A HK 94694 A HK94694 A HK 94694A HK 94694 A HK94694 A HK 94694A HK 94694 A HK94694 A HK 94694A
Authority
HK
Hong Kong
Prior art keywords
naphtyridine
polycyclic
pyrazinopyridine
derivatives
polycyclic quinoline
Prior art date
Application number
HK94694A
Other languages
English (en)
Inventor
Ashit Kumar Ganguly
John Herbert Schwerdt
Richard James Friary
Marvin Ira Siegel
Sidney Randall Smith
Vera Ann Seidl
Edmund J Sybertz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK94694A publication Critical patent/HK94694A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK94694A 1985-06-13 1994-09-08 Polycyclic quinoline, naphtyridine and pyrazinopyridine derivatives HK94694A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74486585A 1985-06-13 1985-06-13
US86178886A 1986-05-15 1986-05-15

Publications (1)

Publication Number Publication Date
HK94694A true HK94694A (en) 1994-09-16

Family

ID=27114362

Family Applications (1)

Application Number Title Priority Date Filing Date
HK94694A HK94694A (en) 1985-06-13 1994-09-08 Polycyclic quinoline, naphtyridine and pyrazinopyridine derivatives

Country Status (19)

Country Link
EP (1) EP0229823B1 (de)
JP (1) JPH0762017B2 (de)
KR (1) KR900004831B1 (de)
AT (1) ATE67764T1 (de)
AU (1) AU591922B2 (de)
CA (1) CA1306255C (de)
DE (1) DE3681719D1 (de)
DK (1) DK70687D0 (de)
GR (1) GR861530B (de)
HK (1) HK94694A (de)
HU (1) HU203098B (de)
IE (1) IE60420B1 (de)
IL (1) IL79110A0 (de)
MY (1) MY101808A (de)
NO (1) NO168177C (de)
NZ (1) NZ216519A (de)
OA (1) OA08480A (de)
PT (1) PT82752B (de)
WO (1) WO1986007359A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609795A1 (de) * 1986-03-22 1987-09-24 Goedecke Ag Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US5366971A (en) * 1987-11-09 1994-11-22 Sandoz Ltd. Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
EP0754388B1 (de) * 1994-04-08 2000-07-26 United Video Properties, Inc. Interaktive abrollbare programmanzeige
DK0787726T3 (da) * 1994-06-14 2002-02-11 Dainippon Pharmaceutical Co Ny forbindelse, fremgangsmåde til fremstilling deraf og antitumor-middel
DE60013994T2 (de) * 1999-08-30 2005-10-06 Maruishi Pharmaceutical Co.Ltd. 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
HU231285B1 (hu) 2018-04-18 2022-08-28 Printnet Kereskedelmi És Szolgáltató Kft. A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH498841A (fr) * 1967-07-13 1970-11-15 Inst Farmaceutyczny Procédé de préparation de benzo-(b,1,8)-naphtyridones-5 substituées
DE2803541A1 (de) 1978-01-27 1979-08-02 Sandoz Ag Neue chinolinderivate, ihre herstellung und verwendung
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents

Also Published As

Publication number Publication date
JPH0762017B2 (ja) 1995-07-05
NO168177B (no) 1991-10-14
WO1986007359A2 (en) 1986-12-18
KR870700622A (ko) 1987-12-30
CA1306255C (en) 1992-08-11
NO870564D0 (no) 1987-02-12
DE3681719D1 (de) 1991-10-31
KR900004831B1 (ko) 1990-07-07
HUT42482A (en) 1987-07-28
ATE67764T1 (de) 1991-10-15
OA08480A (en) 1988-07-29
PT82752A (en) 1986-07-01
PT82752B (pt) 1988-12-15
NZ216519A (en) 1989-02-24
EP0229823A1 (de) 1987-07-29
WO1986007359A3 (en) 1987-04-09
JPS63500518A (ja) 1988-02-25
NO870564L (no) 1987-02-12
IL79110A0 (en) 1986-09-30
GR861530B (en) 1986-12-31
EP0229823B1 (de) 1991-09-25
NO168177C (no) 1992-01-22
DK70687A (da) 1987-02-12
DK70687D0 (da) 1987-02-12
MY101808A (en) 1992-01-31
IE60420B1 (en) 1994-07-13
IE861565L (en) 1986-12-13
AU591922B2 (en) 1989-12-21
HU203098B (en) 1991-05-28
AU6122486A (en) 1987-01-07

Similar Documents

Publication Publication Date Title
IE800761L (en) Naphthyridines
HK94694A (en) Polycyclic quinoline, naphtyridine and pyrazinopyridine derivatives
AU2659088A (en) Method for the treatment of anxiety
HUT45035A (en) Process for producing thiazolone derivatives
NO871507L (no) Fremgangsmaate for fremstilling av arylsubstituerte nafthyridin- og pyridopyrazinderivater.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
PT77802B (en) Process for the preparation of an ointment for treating burns
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
AU597249C (en) Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
RO94514A2 (ro) Procedeu pentru tratarea namolurilor
AU5639886A (en) Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
RO83113A2 (ro) Procedeu pentru tratarea silicei coloidale

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules